TAMPA, Fla., June 13, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that the Board approved a 1-for-1,000 reverse stock split, effective 9:30 a.m.

Warframe's 1999 update is here, bringing with it a new Warframe to earn and a handful of weapons to chase. Cyte-09 strikes from the shadows with his signature Neutralizer, an exalted sniper rifle that ...

TAMPA, Fla., March 04, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that it has received $1,053,605 from the exercise of 75,257,511 previously ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...

Name change reflects investment in, and emphasis on, data-driven, patient-centric care relating to the company’s innovative PRP-PBMC treatment for chronic lung disorders. CAMBRIDGE, Mass., Sept. 08, ...

Like the vast majority of Warframes, Cyte-09 comes with four abilities, offering an interesting kit that can both support allies and dish out the damage. One of the biggest questions I had about his ...

Investing in a good Cyte-09 build pays huge dividends in Warframe if you like hitting high clear speed. On the surface, the marksman image of this Warframe may lead people to believe he's mainly good ...